MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$2,339K
(66.77%↑ Y/Y)
Net loss from
continuing operations
-$2,339K
(45.82%↑ Y/Y)
Net loss from
continuing operations...
-$2,331K
(45.90%↑ Y/Y)
Income tax expense
$8K
(0.00%↑ Y/Y)
Change in fair value of
common stock warrant...
$2,384K
(261.74%↑ Y/Y)
Other income, net
$2,309K
(7348.39%↑ Y/Y)
Interest income
$221K
(-71.74%↓ Y/Y)
Product
$4,858K
Credit loss
-$4,745K
Loss from operations
-$2,500K
(31.47%↑ Y/Y)
Total revenues
$4,858K
(-3.71%↓ Y/Y)
Total operating
expenses
$7,358K
(-15.36%↓ Y/Y)
Change in fair value of
contingent consideration
$2,000K
Gain on sale of
intangible assets
$750K
(-81.25%↓ Y/Y)
Selling, general and
administrative
$7,001K
(-27.38%↓ Y/Y)
Cost of revenues
$3,098K
(4.56%↑ Y/Y)
Research and development
$9K
(-83.02%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)